Strategic partnerships Urology Austin has a track record of collaborating with external entities (HIFU technology partner in 2020, Lone Star Oncology in 2024, Elligo Health Research in 2018). This indicates openness to alliance-based growth, referral networks, and joint patient programs that could be expanded to include research, radiology, radiation oncology, and other specialty collaborations.

Clinical expansion With 18 urologists across 16 locations and a broad service lineup from robotic surgery to radiation oncology and physical therapy, there is potential to upsell integrated care packages, cross-referral arrangements, and remote or centralized scheduling/telehealth offerings to streamline patient pathways and increase utilization of in-house services.

Technology leverage The tech stack and in-house capabilities (daVinci robotic systems, CT-imaging, video urodynamics, digital marketing via Google Tag Manager, and iCIMS for talent) suggest opportunities to offer technology-enabled patient engagement, data-driven outcomes tracking for payers, and vendor partnerships around imaging, robotics, and clinical research participation.

Research and trials Past partnerships with Elligo Health Research position Urology Austin as a potential site for multi-center clinical trials and patient recruitment programs, creating sales opportunities in CRO services, trial management, and patient-centric research collaborations that could drive new revenue streams.

Growth and market fit As the largest private urology practice in Austin with strong regional presence, Urology Austin is well-placed to scale partnerships with regional health systems, oncology centers, and diagnostic providers to expand knot-strong referral networks, bundled care offerings, and preventive care programs aligned with market demand.